Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 9944-9953
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9944
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9944
Figure 3 Shows a large cell poorly differentiated neuroendocrine carcinoma of the pancreas (A, haematoxylin-eosin stain) and a large cell poorly differentiated neuroendocrine carcinoma of the pancreas with its Ki67 proliferative index (B, Ki67: 80%).
- Citation: Crippa S, Partelli S, Belfiori G, Palucci M, Muffatti F, Adamenko O, Cardinali L, Doglioni C, Zamboni G, Falconi M. Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology. World J Gastroenterol 2016; 22(45): 9944-9953
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/9944.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.9944